{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:23:51Z","timestamp":1793820231016,"version":"4.6.1"},"reference-count":168,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Ovarian cancer (OC) remains one of the most aggressive gynecological malignancies, with a five-year survival rate below 45% despite the recent advances in the introduction of targeted therapy. Moreover, immunotherapy, such as immune checkpoint inhibitors, does not improve the survival of OC patients. Lack of sufficient knowledge in understanding the complexity of the tumor microenvironment likely confers the treatment ineffectiveness. Recently, tumor-associated macrophages (TAMs) and tumor-associated neutrophils (TANs) have garnered research attention as they shape the tumor immune microenvironment, which plays a crucial role in disease progression and treatment response. This article reviews the complex roles of these innate immune cells in OC progression. TAMs represent a significant component of the immune infiltrate in OC, exhibiting considerable functional plasticity and can shift between anti-tumoral (M1) and pro-tumoral (M2) phenotypes. M2-like TAMs typically predominate in the tumor microenvironment, which aids in the development of immune suppression and disease progression. They also contribute to chemoresistance and metastasis; hence, their presence in tumors is associated with a worse prognosis. TANs, like TAMs, exhibit N1\/N2 polarization and influence tumor progression through the formation of neutrophil extracellular traps. Understanding the biological interactions between various immune cells and cancer cells may offer new therapeutic opportunities. This review sheds light on the dynamic ecological transformation of the OC tumor microenvironment and highlights the potential of targeting TAM\/TAN-mediated processes to improve OC treatment outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1677441","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:58:10Z","timestamp":1762430290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Macrophages and neutrophils in ovarian cancer microenvironment"],"prefix":"10.3389","volume":"16","author":[{"given":"Kuang-Chao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-Sian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/jamaoncol.2020.5945","article-title":"Efficacy and safety of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of recurrent ovarian cancer: A phase 2 nonrandomized clinical trial","volume":"7","author":"Zsiros","year":"2021","journal-title":"JAMA Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49512-6","article-title":"Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells","volume":"15","author":"Shender","year":"2024","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2560","article-title":"Ovarian cancer: Current status and strategies for improving therapeutic outcomes","volume":"8","author":"Chandra","year":"2019","journal-title":"Cancer Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9279","DOI":"10.3390\/ijms24119279","article-title":"Crosstalk of immune cells and platelets in an ovarian cancer microenvironment and their prognostic significance","volume":"24","author":"Pankowska","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.cll.2023.08.004","article-title":"Molecular pathology of ovarian epithelial neoplasms: predictive, prognostic, and emerging biomarkers","volume":"44","author":"Ordulu","year":"2024","journal-title":"Clin Lab Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01874","article-title":"Pembrolizumab in patients with microsatellite instability-high advanced endometrial cancer: results from the KEYNOTE-158 study","volume":"40","author":"O'Malley","year":"2022","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2998","article-title":"Classification of current anticancer immunotherapies","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","first-page":"116349","DOI":"10.1016\/j.bcp.2024.116349","article-title":"CAR-T therapy for ovarian cancer: Recent advances and future directions","volume":"226","author":"Xin","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B16","doi-asserted-by":"publisher","first-page":"107952","DOI":"10.1016\/j.isci.2023.107952","article-title":"Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"key":"B17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040564","article-title":"Tumor-associated neutrophils in cancer: going pro","volume":"11","author":"Wu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cell.2019.05.047","article-title":"Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors","volume":"178","author":"Ponzetta","year":"2019","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.it.2015.11.008","article-title":"Neutrophils in the tumor microenvironment","volume":"37","author":"Powell","year":"2016","journal-title":"Trends Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00038","article-title":"Targeting tumor-associated macrophages as a potential strategy to enhance the response to immune checkpoint inhibitors","volume":"6","author":"Cassetta","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2014.11.001","article-title":"Balancing the innate immune system in tumor development","volume":"25","author":"Hagerling","year":"2015","journal-title":"Trends Cell Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10080251","article-title":"The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer","volume":"10","author":"Savant","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000123","article-title":"Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer)","volume":"34","author":"Seidman","year":"2015","journal-title":"Int J Gynecol Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"126295","DOI":"10.1155\/2010\/126295","article-title":"Precursor lesions of high-grade serous ovarian carcinoma: morphological and molecular characteristics","volume":"2010","author":"Gross","year":"2010","journal-title":"J Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad011","article-title":"Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis","volume":"115","author":"Fu","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093125","article-title":"The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: A focus on innate immunity cells as therapeutic effectors","volume":"21","author":"Baci","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2017.10.004","article-title":"DAMP-TLR-cytokine axis dictates the fate of tumor","volume":"104","author":"Patidar","year":"2018","journal-title":"Cytokine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092220","article-title":"Tumor-associated macrophages and ovarian cancer: implications for therapy","volume":"14","author":"Schweer","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0492-7","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J Biomed Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1641399","article-title":"Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K\/AKT\/NF-\u03baB-signaling pathway to inhibit the polarization of M2 TAMs","volume":"15","author":"Le","year":"2025","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1641399","article-title":"Investigating the oncogenic and immunological implications of YTHDF1 in ovarian cancer","volume":"19","author":"Yin","year":"2025","journal-title":"Biologics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s12672-025-02891-8","article-title":"CYBB as a potential therapeutic target through influencing ferroptosis and macrophage in ovarian cancer","volume":"16","author":"Ye","year":"2025","journal-title":"Discov Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-24-0440","article-title":"Targeting LxCxE cleft pocket of retinoblastoma protein in immunosuppressive macrophages inhibits ovarian cancer progression","volume":"111","author":"Tcyganov","year":"2025","journal-title":"Cancer Immunol Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17142325","article-title":"Divergent immune-metabolic profiles in endometriosis and ovarian cancer: A cross-sectional analysis","volume":"17","author":"Neri","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002829","article-title":"Distinct roles of HMOX1 on tumor epithelium and macrophage for regulation of immune microenvironment in ovarian cancer","volume":"111","author":"Liu","year":"2025","journal-title":"Int J Surg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e70701","DOI":"10.1111\/jcmm.70701","article-title":"CD81 Aggravates Ovarian Cancer Progression via p-Cresyl Sulfate-Mediated Mitophagy in Tim4(+) Tumour-Associated Macrophages","volume":"29","author":"Ni","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-025-02128-7","article-title":"The CXCL8-CXCR2 axis promotes M2 macrophage polarization in ovarian cancer via RASGRP4-mediated mTOR-STAT3 signaling","volume":"30","author":"Ren","year":"2025","journal-title":"Apoptosis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-025-03522-w","article-title":"Activated MAFB in ovarian cancer promotes cytoskeletal remodeling and immune microenvironment suppression by interfering with m6A modifications through WTAP competition","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"},{"key":"B43","doi-asserted-by":"publisher","first-page":"112876","DOI":"10.1016\/j.intimp.2024.112876","article-title":"Myc-mediated inhibition of HIF1a degradation promotes M2 macrophage polarization and impairs CD8 T cell function through lactic acid secretion in ovarian cancer","volume":"141","author":"Liu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e70034","DOI":"10.1002\/ccs3.70034","article-title":"UBD-mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion","volume":"19","author":"Zhang","year":"2025","journal-title":"J Cell Commun Signal"},{"key":"B45","doi-asserted-by":"publisher","first-page":"117170","DOI":"10.1016\/j.bcp.2025.117170","article-title":"Promoting tumor cell secretion of IL18 to induce reprogramming of tumor-associated macrophages - The novel anticancer mechanism of anlotinib in ovarian cancer","volume":"241","author":"Zhang","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2537710","DOI":"10.1080\/2162402X.2025.2537710","article-title":"Patient-derived ovarian cancer models demonstrate the influence of tumor-associated macrophages on therapeutic response","volume":"14","author":"Nikeghbal","year":"2025","journal-title":"Oncoimmunology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"177157","DOI":"10.1016\/j.ejphar.2024.177157","article-title":"Cinobufagin modulates vasculogenic mimicry and tumor-associated macrophages to inhibit ovarian cancer progression","volume":"987","author":"Wang","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"152863","DOI":"10.1016\/j.imbio.2024.152863","article-title":"Nucleotide receptor P2X7\/STAT6 pathway regulates macrophage M2 polarization and its application in CAR-T immunotherapy","volume":"230","author":"Si","year":"2025","journal-title":"Immunobiology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"114011","DOI":"10.1016\/j.intimp.2024.114011","article-title":"OTUD4-mediated inhibition of YAP1 signaling pathway in ovarian cancer: Implications for macrophage polarization and recruitment","volume":"147","author":"Li","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"104913","DOI":"10.1016\/j.cellimm.2024.104913","article-title":"KLHDC8A knockdown in normal ovarian epithelial cells promoted the polarization of pro-tumoral macrophages via the C5a\/C5aR\/p65 NF\u03baB signaling pathway","author":"Fang","year":"2025","journal-title":"Cell Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molimm.2025.01.007","article-title":"UBE2I depletion regulated tumor-associated macrophage polarization into M1 type through reprogramming glycolysis and increases immunotherapy efficacy of anti-PD-L1 in ovarian cancer","volume":"179","author":"Zhao","year":"2025","journal-title":"Mol Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/cells14030214","article-title":"Enhanced expression of TRIM46 in ovarian cancer cells induced by tumor-associated macrophages promotes invasion via the wnt\/\u03b2-catenin pathway","volume":"14","author":"Wang","year":"2025","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13048-025-01616-3","article-title":"Tumour-derived exosomal miR-205 promotes ovarian cancer cell progression through M2 macrophage polarization via the PI3K\/Akt\/mTOR pathway","volume":"18","author":"He","year":"2025","journal-title":"J Ovarian Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13048-025-01618-1","article-title":"TAM-derived exosomal miR-589-3p accelerates ovarian cancer progression through BCL2L13","volume":"18","author":"Wang","year":"2025","journal-title":"J Ovarian Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2412881","DOI":"10.1002\/advs.202412881","article-title":"CpG-based nanovaccines enhance ovarian cancer immune response by gbp2-mediated remodeling of tumor-associated macrophages","volume":"12","author":"Xiong","year":"2025","journal-title":"Advanced Sci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"104932","DOI":"10.1016\/j.cellimm.2025.104932","article-title":"In vitro ovarian tumor-conditioned CD163+ human macrophages retain phagocytic response to CD47 blockade","author":"Antonsen","year":"2025","journal-title":"Cell Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1512086","article-title":"GNA15 predicts poor outcomes as a novel biomarker related to M2 macrophage infiltration in ovarian cancer","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"114318","DOI":"10.1016\/j.intimp.2025.114318","article-title":"The interaction between IL-33 and TRIM28 in the regulation of macrophage polarization in an ST2-independent manner","volume":"152","author":"Zhao","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"125483","DOI":"10.1016\/j.ijpharm.2025.125483","article-title":"CD44-targeted nanoparticles for remodeling the tumor microenvironment in a 3D macrophage-embedded ovarian cancer model with stem cell-like features","volume":"674","author":"Shrestha","year":"2025","journal-title":"Int J Pharm"},{"key":"B60","doi-asserted-by":"publisher","first-page":"114479","DOI":"10.1016\/j.intimp.2025.114479","article-title":"F-box only protein 25-mediated \u03b1-actinin 1 upregulation drives ovarian cancer progression via ERK1\/2 signaling in tumor cells and macrophage M2 polarization","volume":"153","author":"Sun","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12032-025-02682-9","article-title":"Curcumin suppresses Malignant behaviors of ovarian cancer through regulation of tumor-associated macrophages","volume":"42","author":"Li","year":"2025","journal-title":"Med Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1038\/s41467-025-57870-y","article-title":"Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction","volume":"16","author":"Osborn","year":"2025","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.25259\/Cytojournal_241_2024","article-title":"A new perspective: Acyl-CoA synthetase long-chain family member 4 inhibits ubiquitin-specific protease 7-induced epithelial ovarian cancer progression by inducing ferroptosis and M1 macrophage polarization","volume":"22","author":"Qi","year":"2025","journal-title":"Cytojournal"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3880719","DOI":"10.1155\/ancp\/3880719","article-title":"Gallic acid inhibits the proliferation and migration of ovarian cancer cells via inhibition of the PI3K-AKT pathway and promoting M1-like macrophage polarization","volume":"2025","author":"Meng","year":"2025","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s12672-025-02512-4","article-title":"PTTG1 promotes M2 macrophage polarization via the cGMP-PKG signaling pathway and facilitates EMT progression in human epithelial ovarian cancer cells","volume":"16","author":"Tian","year":"2025","journal-title":"Discov Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"114900","DOI":"10.1016\/j.intimp.2025.114900","article-title":"Integrated analyses reveal CXCL11 as an inhibitor in ovarian cancer and its facilitation of an M1 macrophage switch via the JAK2\/STAT1 pathway","volume":"159","author":"Ye","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051021","article-title":"SNX10 is involved in ovarian cancer cell metastasis by repolarizing tumor-associated macrophages through mTOR1\/lysosomes pathway","volume":"13","author":"Chai","year":"2025","journal-title":"Biomedicines"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e04436","DOI":"10.1002\/advs.202504436","article-title":"Exosomal CMTM4 induces immunosuppressive macrophages to promote ovarian cancer progression and attenuate anti-PD-1 immunotherapy","volume":"12","author":"Yin","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B69","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00018-025-05731-8","article-title":"Tumor-associated macrophages contribute to cisplatin resistance via regulating Pol \u03b7-mediated translesion DNA synthesis in ovarian cancer","volume":"82","author":"Chatterjee","year":"2025","journal-title":"Cell Mol Life Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage M1\u00e2\u20ac\u201cM2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00691","article-title":"Clinical relevance and immunosuppressive pattern of circulating and infiltrating subsets of myeloid-derived suppressor cells (MDSCs) in epithelial ovarian cancer","volume":"10","author":"Ok\u0142a","year":"2019","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400983101","article-title":"Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria","volume":"101","author":"Verreck","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O\u2019Neill","year":"2016","journal-title":"J Exp Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.isci.2020.101441","article-title":"Residue-specific message encoding in CD40-ligand","volume":"23","author":"Sarode","year":"2020","journal-title":"iScience"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukaryotGeneExpr.2016015920","article-title":"Macrophage polarization: implications on metabolic diseases and the role of exercise","volume":"26","author":"Silveira","year":"2016","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512032","article-title":"Impact of lipid metabolism on macrophage polarization: implications for inflammation and tumor immunity","volume":"24","author":"Vassiliou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01047-4","article-title":"Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity","volume":"22","author":"Di Conza","year":"2021","journal-title":"Nat Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1757-2215-7-19","article-title":"A high M1\/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients","volume":"7","author":"Zhang","year":"2014","journal-title":"J Ovarian Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"109539","DOI":"10.1016\/j.cellsig.2020.109539","article-title":"GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma","volume":"68","author":"El-Arabey","year":"2020","journal-title":"Cell Signal"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01731","article-title":"Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e00738","DOI":"10.1002\/adbi.202400738","article-title":"Inhibition of glutamine metabolism attenuates tumor progression through remodeling of the macrophage immune microenvironment","volume":"9","author":"Li","year":"2025","journal-title":"Adv Biol (Weinh)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/816460","article-title":"Understanding the mysterious M2 macrophage through activation markers and effector mechanisms","volume":"2015","author":"R\u0151szer","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathology: Mech Disease"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0277285","DOI":"10.1371\/journal.pone.0277285","article-title":"Upregulation of programmed death ligand-1 in tumor-associated macrophages affects chemotherapeutic response in ovarian cancer cells","volume":"18","author":"Jang","year":"2023","journal-title":"PloS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"113474","DOI":"10.1016\/j.biopha.2022.113474","article-title":"CCL2 overexpression is associated with paclitaxel resistance in ovarian cancer cells via autocrine signaling and macrophage recruitment","volume":"153","author":"Yang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/life13112192","article-title":"Recurrent somatic copy number alterations and their association with oncogene expression levels in high-grade ovarian serous carcinoma","volume":"13","author":"Esplen","year":"2023","journal-title":"Life (Basel)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e12996","DOI":"10.1111\/aji.12996","article-title":"Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2-type macrophage polarization","volume":"80","author":"Mlynska","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41467-023-37227-z","article-title":"Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps","volume":"14","author":"Wang","year":"2023","journal-title":"Nat Commun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cmet.2018.09.002","article-title":"PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers","volume":"29","author":"Gentric","year":"2019","journal-title":"Cell Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0637-x","article-title":"An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment","volume":"38","author":"Motohara","year":"2019","journal-title":"Oncogene"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.cmet.2019.02.016","article-title":"Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression","volume":"29","author":"Goossens","year":"2019","journal-title":"Cell Metab"},{"key":"B94","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13045-021-01198-9","article-title":"Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers","volume":"14","author":"Xu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aav3334","article-title":"Tumor-derived TGF-\u03b2 inhibits mitochondrial respiration to suppress IFN-\u03b3 production by human CD4(+) T cells","volume":"12","author":"Dimeloe","year":"2019","journal-title":"Sci Signal"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00758","article-title":"Tumor microenvironment in ovarian cancer: function and therapeutic strategy","volume":"8","author":"Yang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3390\/cancers3043740","article-title":"Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma","volume":"3","author":"Liguori","year":"2011","journal-title":"Cancers (Basel)"},{"key":"B98","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12935-024-03518-8","article-title":"The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis","volume":"24","author":"Yu","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.297","article-title":"Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer","volume":"117","author":"Wang","year":"2017","journal-title":"Br J Cancer"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3608","article-title":"Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells","volume":"67","author":"Schumacher","year":"2007","journal-title":"Cancer Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116215","article-title":"Spheroid formation and peritoneal metastasis in ovarian cancer: the role of stromal and immune components","volume":"23","author":"Rakina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00307.x","article-title":"Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up","author":"Rudlowski","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2004.01.014","article-title":"Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients","volume":"37","author":"Kassim","year":"2004","journal-title":"Clin Biochem"},{"key":"B104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13048-024-01398-0","article-title":"Pre-operative plasma VEGF-C levels portend recurrence in epithelial ovarian cancer patients and is a bankable prognostic marker even in the initial assessment of a patient","volume":"17","author":"Bhaskari","year":"2024","journal-title":"J Ovarian Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-999-0373-0","article-title":"Markedly elevated levels of vascular endothelial growth factor in Malignant ascites","volume":"6","author":"Zebrowski","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12905-023-02879-y","article-title":"Efficacy and safety of VEGF\/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Womens Health"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4375","article-title":"Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice","volume":"67","author":"Robinson-Smith","year":"2007","journal-title":"Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3341","article-title":"Alternatively-activated macrophages upregulate mesothelial expression of P-selectin to enhance adhesion of ovarian cancer cells","volume":"78","author":"Carroll","year":"2018","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1084\/jem.2018076508222019c","article-title":"Correction: Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer","volume":"216","author":"Gao","year":"2019","journal-title":"J Exp Med"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2018.1564567","article-title":"M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression","volume":"20","author":"Zeng","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"B111","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.3390\/cancers16244187","article-title":"Interleukin-6 modulation in ovarian cancer necessitates a targeted strategy: from the approved to emerging therapies","volume":"16","author":"Amer","year":"2024","journal-title":"Cancers"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1741","article-title":"Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities","volume":"7","author":"Ghoneum","year":"2018","journal-title":"Cancer Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.52","article-title":"Neutrophils in cancer: neutral no more","volume":"16","author":"Coffelt","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.8.2012.2012","article-title":"Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products","volume":"80","author":"Colotta","year":"1992","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-149575","article-title":"Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3","volume":"112","author":"van Raam","year":"2008","journal-title":"Blood"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-259028","article-title":"In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5","volume":"116","author":"Pillay","year":"2010","journal-title":"4 days Blood"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.05.031","article-title":"Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of Malignant cell intravasation","volume":"179","author":"Bekes","year":"2011","journal-title":"Am J Pathol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-1026-0","article-title":"Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer","volume":"123","author":"Yang","year":"2020","journal-title":"Br J Cancer"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70021","article-title":"Immunosuppressive JAG2(+) tumor-associated neutrophils hamper PD-1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells","volume":"45","author":"Wang","year":"2025","journal-title":"Cancer Commun (Lond)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-024-01366-6","article-title":"NETosis genes and pathomic signature: A novel prognostic marker for ovarian serous cystadenocarcinoma","volume":"38","author":"Zhan","year":"2025","journal-title":"J Imaging Inform Med"},{"key":"B123","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","article-title":"Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10","volume":"43","author":"Lee","year":"2025","journal-title":"Cancer Cell"},{"key":"B124","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ygyno.2024.12.006","article-title":"Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancer","volume":"193","author":"Ricciuti","year":"2025","journal-title":"Gynecol Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1038\/s41598-025-97548-5","article-title":"Assessment of lncRNA biomarkers based on NETs for prognosis and therapeutic response in ovarian cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae166","article-title":"G-CSF induces neutrophil extracellular traps formation and promotes ovarian cancer peritoneal dissemination","volume":"116","author":"Bun","year":"2024","journal-title":"J Leukoc Biol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e70302","DOI":"10.1111\/jcmm.70302","article-title":"A neutrophil extracellular traps-related signature predicts clinical outcomes and identifies immune landscape in ovarian cancer","volume":"28","author":"Zhang","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1111344","article-title":"Increased levels of NETosis biomarkers in high-grade serous ovarian cancer patients' biofluids: Potential role in disease diagnosis and management","volume":"14","author":"Tom\u00e1s-P\u00e9rez","year":"2023","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.15556","article-title":"Circulating markers of neutrophil extracellular traps (NETs) in patients with ovarian tumors","volume":"42","author":"Dobilas","year":"2022","journal-title":"Anticancer Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e09730","DOI":"10.1016\/j.heliyon.2022.e09730","article-title":"Neutrophil extracellular traps (NETs) reduce the diffusion of doxorubicin which may attenuate its ability to induce apoptosis of ovarian cancer cells","volume":"8","author":"Tamura","year":"2022","journal-title":"Heliyon"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020505","article-title":"Neutrophil extracellular trap formation correlates with favorable overall survival in high grade ovarian cancer","volume":"12","author":"Muqaku","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \"N1\" versus \"N2\" TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s12307-014-0147-5","article-title":"The multifaceted roles neutrophils play in the tumor microenvironment","volume":"8","author":"Sionov","year":"2015","journal-title":"Cancer Microenviron"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-3614","article-title":"TRPM2 mediates neutrophil killing of disseminated tumor cells","volume":"78","author":"Gershkovitz","year":"2018","journal-title":"Cancer Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-844548","article-title":"Neutrophil plasticity in the tumor microenvironment","volume":"133","author":"Giese","year":"2019","journal-title":"Blood"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-1808","article-title":"Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils","volume":"64","author":"Koga","year":"2004","journal-title":"Cancer Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-59568\/v2","article-title":"N2-neutrophils promote invasion and metastasis of ovarian cancer by upregulating MAPK signaling","author":"Li","year":"2022","journal-title":"Res Square"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-010389","article-title":"Suppression of T-cell functions by human granulocyte arginase","volume":"108","author":"Munder","year":"2006","journal-title":"Blood"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis","volume":"109","author":"Demers","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1591","article-title":"Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress","volume":"76","author":"Tohme","year":"2016","journal-title":"Cancer Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00048","article-title":"A proposed role for neutrophil extracellular traps in cancer immunoediting","volume":"4","author":"Berger-Achituv","year":"2013","journal-title":"Front Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00373","article-title":"NETosis in cancer \u2013 platelet\u2013neutrophil crosstalk promotes tumor-associated pathology","volume":"7","author":"Olsson","year":"2016","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065995","article-title":"Neutrophil extracellular traps and cancer: trapping our attention with their involvement in ovarian cancer","volume":"24","author":"Casta\u00f1o","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20181170","article-title":"Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum","volume":"216","author":"Lee","year":"2019","journal-title":"J Exp Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0339-8","article-title":"Mitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer","volume":"120","author":"Singel","year":"2019","journal-title":"Br J Cancer"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67484","article-title":"Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis","volume":"123","author":"Cools-Lartigue","year":"2013","journal-title":"J Clin Invest"},{"key":"B148","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1158\/1538-7445.AM2024-5329","article-title":"Ovarian cancer predisposes neutrophils to form neutrophil extracellular traps (NETs)","volume":"84","author":"Yamamoto","year":"2024","journal-title":"Cancer Res"},{"key":"B149","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13045-019-0836-0","article-title":"Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response","volume":"13","author":"Yang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"101595","DOI":"10.1016\/j.smim.2022.101595","article-title":"The role of neutrophil extracellular traps in cancer progression and metastasis","volume":"57","author":"De Meo","year":"2022","journal-title":"Semin Immunol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052929","article-title":"Neutrophils at the crossroads: unraveling the multifaceted role in the tumor microenvironment","volume":"25","author":"Awasthi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000279","article-title":"Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic Malignancy","volume":"26","author":"Hashiguchi","year":"2015","journal-title":"Anticancer Drugs"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1038\/nature14282","article-title":"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0081-8","article-title":"NETs awaken sleeping cancer cells","volume":"18","author":"Bordon","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.08.012","article-title":"Neutrophils: Cinderella of innate immune system","volume":"10","author":"Kumar","year":"2010","journal-title":"Int\u00a0Immunopharmacol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","article-title":"Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib","volume":"150","author":"Zhou","year":"2016","journal-title":"Gastroenterology"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1481","article-title":"Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer","volume":"24","author":"Wouters","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0373-7","article-title":"Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms","volume":"21","author":"Kim","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"154739","DOI":"10.1016\/j.prp.2023.154739","article-title":"Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer","volume":"249","author":"Song","year":"2023","journal-title":"Pathol Res Pract"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005968","article-title":"Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma","volume":"11","author":"Truxova","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12967-023-04479-8","article-title":"The application of HER2 and CD47 CAR-macrophage in ovarian cancer","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41467-021-20893-2","article-title":"CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy","volume":"12","author":"Rodriguez-Garcia","year":"2021","journal-title":"Nat Commun"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-3299","article-title":"Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals","volume":"75","author":"Cedervall","year":"2015","journal-title":"Cancer Res"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01749","article-title":"The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis","volume":"11","author":"Masucci","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677441\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:58:12Z","timestamp":1762430292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1677441\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":168,"alternative-id":["10.3389\/fimmu.2025.1677441"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1677441","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"article-number":"1677441"}}